FDA Approved: OPTISON PERFLUTREN PROTEIN-TYPE A MICROSPHERES — Supplemental Application (GE Healthcare Inc.)

View source ↗

Summary

The FDA approved a supplemental application for GE Healthcare's Optison perflutren protein-type A microspheres (human albumin microspheres and perflutren).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Diseases

Drugs mentioned

• Optison

Snippet

SUPPL AP for OPTISON PERFLUTREN PROTEIN-TYPE A MICROSPHERES (HUMAN ALBUMIN MICROSPHERES AND PERFLUTREN)